JP2009504576A5 - - Google Patents

Download PDF

Info

Publication number
JP2009504576A5
JP2009504576A5 JP2008525352A JP2008525352A JP2009504576A5 JP 2009504576 A5 JP2009504576 A5 JP 2009504576A5 JP 2008525352 A JP2008525352 A JP 2008525352A JP 2008525352 A JP2008525352 A JP 2008525352A JP 2009504576 A5 JP2009504576 A5 JP 2009504576A5
Authority
JP
Japan
Prior art keywords
composition
glutamine
source
use according
glutamine source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008525352A
Other languages
English (en)
Japanese (ja)
Other versions
JP5194207B2 (ja
JP2009504576A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2006/001319 external-priority patent/WO2007016791A1/en
Publication of JP2009504576A publication Critical patent/JP2009504576A/ja
Publication of JP2009504576A5 publication Critical patent/JP2009504576A5/ja
Application granted granted Critical
Publication of JP5194207B2 publication Critical patent/JP5194207B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008525352A 2005-08-11 2006-08-11 腹腔内グルタミンによる術後癒着形成の減少 Active JP5194207B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70717305P 2005-08-11 2005-08-11
US60/707,173 2005-08-11
PCT/CA2006/001319 WO2007016791A1 (en) 2005-08-11 2006-08-11 Reducing post-operative adhesion formation with intraperitoneal glutamine

Publications (3)

Publication Number Publication Date
JP2009504576A JP2009504576A (ja) 2009-02-05
JP2009504576A5 true JP2009504576A5 (https=) 2009-09-24
JP5194207B2 JP5194207B2 (ja) 2013-05-08

Family

ID=37727066

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008525352A Active JP5194207B2 (ja) 2005-08-11 2006-08-11 腹腔内グルタミンによる術後癒着形成の減少

Country Status (14)

Country Link
US (5) US20100260819A1 (https=)
EP (1) EP1940439B1 (https=)
JP (1) JP5194207B2 (https=)
AT (1) ATE485829T1 (https=)
AU (1) AU2006279218B2 (https=)
CA (1) CA2618600C (https=)
CY (1) CY1112051T1 (https=)
DE (1) DE602006017864D1 (https=)
DK (1) DK1940439T3 (https=)
ES (1) ES2355159T3 (https=)
PL (1) PL1940439T3 (https=)
PT (1) PT1940439E (https=)
SI (1) SI1940439T1 (https=)
WO (1) WO2007016791A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1940439E (pt) 2005-08-11 2010-12-17 Univ Saskatchewan Redução da formação de aderências pós-operatórias com glutamina intraperitoneal
CA2578647A1 (en) * 2007-02-15 2008-08-15 University Of Saskatchewan Reducing post-operative adhesion formation with intraperitoneal glutamine
JP5433424B2 (ja) 2007-03-02 2014-03-05 シュトプロテック ゲーエムベーハー グルタミン残基を含む炭水化物系腹膜透析液
US20100082113A1 (en) * 2008-04-29 2010-04-01 Peter Gingras Tissue repair implant
RU2578426C2 (ru) * 2010-06-28 2016-03-27 Эдитерапьютикс, Инк. Лечение келоидов
WO2014027545A1 (ja) 2012-08-16 2014-02-20 ニプロ株式会社 癒着防止材
WO2017190148A1 (en) * 2016-04-29 2017-11-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for the prevention and treatment of surgical adhesions
EP3471791B1 (en) 2016-06-15 2020-08-05 Tubitak Multifunctional hernia patch
US10500318B1 (en) * 2018-07-03 2019-12-10 Temple Therapeutics BV Dosing regimens for treating hypoxia-associated tissue damage
WO2022234489A1 (en) 2021-05-07 2022-11-10 Temple Therapeutics BV Methods of treating fibrosis and hypoxia-associated damage to peripheral nerves
WO2025163204A1 (en) 2024-02-01 2025-08-07 Temple Therapeutics BV Glutamine source for use in methods and compositions for reducing or preventing synovial joint adhesions or fibrosis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2026881A1 (en) * 1989-02-08 1990-08-09 Masao Tanihara Peptide and adsorbent thereof immobilized on carrier
US5248697A (en) 1990-09-20 1993-09-28 Brigham And Women's Hospital Enhancement of glutathione levels with glutamine
CA2114290C (en) * 1993-01-27 2006-01-10 Nagabushanam Totakura Post-surgical anti-adhesion device
US5425740A (en) * 1994-05-17 1995-06-20 Hutchinson, Jr.; William B. Endoscopic hernia repair clip and method
US6965014B1 (en) * 1996-01-16 2005-11-15 Baxter International Inc. Fibrin material and method for producing and using the same
US6280745B1 (en) * 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
US5693671A (en) * 1996-05-01 1997-12-02 Harbor-Ucla Research And Education Institute L-glutamine therapy for sickle cell diseases and thalassemia
GB9609993D0 (en) 1996-05-14 1996-07-17 Norbrook Lab Ltd Oral rehydration product
US6797729B1 (en) * 1996-06-28 2004-09-28 Baxter International Inc. Therapeutic glutamine and N-actyl-cysteine composition
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6495579B1 (en) * 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
WO1999009982A1 (en) * 1997-08-25 1999-03-04 Harold Brem Prevention of adhesions and excessive scar formation using angiogenesis inhibitors
CA2330939A1 (en) * 1998-06-16 1999-12-23 Biogen, Inc. Variant type ii tgf-beta receptor fusion proteins and methods
JP2002521423A (ja) 1998-07-31 2002-07-16 コリア インスティチュート オブ サイエンス アンド テクノロージ 遺伝子又は薬物運搬体としての脂質エマルジョン及び固形脂質微粒子
US6613070B2 (en) * 1998-08-04 2003-09-02 Baxter International Inc. System and method for sealing vascular penetrations with hemostatic gels
US20030007951A1 (en) 2000-08-23 2003-01-09 Richard Franklin Treatment of trauma
CN100382796C (zh) * 2002-10-08 2008-04-23 艾博特公司 用于提供谷氨酰胺的方法和组合物
CA2538680A1 (en) 2003-09-26 2005-04-07 Bristol-Myers Squibb Company Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
PT1940439E (pt) * 2005-08-11 2010-12-17 Univ Saskatchewan Redução da formação de aderências pós-operatórias com glutamina intraperitoneal

Similar Documents

Publication Publication Date Title
JP6568519B2 (ja) 医療用被覆器具
US20070286892A1 (en) Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
JP2010520186A5 (https=)
JP2009504576A5 (https=)
CN102006893A (zh) 粘膜组织敷料及其使用方法
WO2020087181A1 (en) Foam compositions, foam matrices and methods
JP2013100347A5 (https=)
JP2009269923A5 (https=)
JP2005527535A5 (https=)
IL203747A (en) Use of a steroid sex precursor in the manufacture of a 13mg dose or less for daily dosing through the vagina to treat vaginal diseases and a vaginal pharmacological preparation containing it
IL174562A0 (en) Oros push-stick for controlled delivery of active agent
JP2013121983A5 (https=)
WO2010039641A3 (en) Long term drug delivery devices with polyurethane-based polymers and their manufacture
PL2062602T3 (pl) Nowy, nietoksyczny i biodegradowalny klej biologiczny przeznaczony do stosowania w chirurgii jamy brzusznej
WO2005043971A3 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
JP2019534288A5 (https=)
EA201100313A1 (ru) Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
JP2005524648A5 (https=)
NZ605469A (en) Nalbuphine-based formulations and uses thereof
WO2007098479A3 (en) Localized insulin delivery for bone healing
WO2004037207A3 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
JP2012508256A5 (https=)
JP2010520184A5 (https=)
JP2004532892A5 (https=)
IL194500A (en) A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above